Insider Trading activities of Bicycle Therapeutics Plc (BCYC)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bicycle Therapeutics Plc (BCYC) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bicycle Therapeutics Plc since year 2005. Table 2 shows the detailed insider transactions of Bicycle Therapeutics Plc since 2005. The reporting company's ticker symbol is BCYC. The reporting company's CIK number is 1761612.
The total value of stock buying since 2005 is $45,860,850.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Bicycle Therapeutics Plc (BCYC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-05 3,275,775 $45,860,850 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Bicycle Therapeutics Plc insiders (BCYC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-05-29 Cambridge Innovation Capital (jersey) Ltd (10% Owner) Buy 314,286 14.00 4,400,004
2019-05-28 Aquila Investments Iv Buy 364,286 14.00 5,100,004
2019-05-28 Harland Deborah (Director) Buy 385,714 14.00 5,399,996
2019-05-28 Anstey Michael (Director) Buy 314,286 14.00 4,400,004
2019-05-28 Sv Life Sciences Fund V Strategic Partners, L.p. (10% Owner) Buy 385,715 14.00 5,400,010
2019-05-28 Bingham Kate (Director) Buy 385,715 14.00 5,400,010
2019-05-28 Glaxosmithkline Plc Buy 385,714 14.00 5,399,996
2019-05-28 Novartis Ag (10% Owner) Buy 168,630 14.00 2,360,820
2019-05-27 Ng Carolyn (Director) Buy 571,429 14.00 8,000,006

Insider trading activities including stock purchases, stock sales, and option exercises of BCYC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bicycle Therapeutics Plc (symbol BCYC, CIK number 1761612) see the Securities and Exchange Commission (SEC) website.